BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 224 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2021. The put-call ratio across all filers is 1.19 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $9,161,000 | -89.7% | 62,875 | -91.6% | 0.01% | -85.3% |
| Q1 2022 | $89,270,000 | -12.2% | 752,883 | +2.0% | 0.07% | -20.0% |
| Q4 2021 | $101,731,000 | +40.8% | 738,199 | +41.9% | 0.08% | +37.1% |
| Q3 2021 | $72,251,000 | +39598.4% | 520,124 | +27669.6% | 0.06% | – |
| Q2 2021 | $182,000 | +36.8% | 1,873 | -3.7% | 0.00% | – |
| Q1 2021 | $133,000 | -35.4% | 1,945 | -18.9% | 0.00% | – |
| Q4 2020 | $206,000 | +32.1% | 2,398 | 0.0% | 0.00% | – |
| Q3 2020 | $156,000 | -10.9% | 2,398 | 0.0% | 0.00% | – |
| Q2 2020 | $175,000 | +373.0% | 2,398 | +118.0% | 0.00% | – |
| Q1 2020 | $37,000 | -38.3% | 1,100 | 0.0% | 0.00% | – |
| Q4 2019 | $60,000 | – | 1,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |